Albert D Mason Inc. Has $940,000 Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Albert D Mason Inc. boosted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.3% in the fourth quarter, Holdings Channel reports. The firm owned 10,596 shares of the company’s stock after purchasing an additional 139 shares during the period. Albert D Mason Inc.’s holdings in U.S. Physical Therapy were worth $940,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of USPH. Quest Partners LLC increased its holdings in shares of U.S. Physical Therapy by 2,808.3% in the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after acquiring an additional 337 shares in the last quarter. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 4.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after purchasing an additional 9,434 shares during the period. Dimensional Fund Advisors LP increased its stake in U.S. Physical Therapy by 2.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock worth $39,173,000 after purchasing an additional 10,462 shares in the last quarter. Renaissance Technologies LLC raised its holdings in U.S. Physical Therapy by 763.7% during the 2nd quarter. Renaissance Technologies LLC now owns 69,523 shares of the company’s stock worth $6,425,000 after buying an additional 61,474 shares during the period. Finally, Hsbc Holdings PLC bought a new position in U.S. Physical Therapy in the second quarter valued at approximately $260,000.

U.S. Physical Therapy Stock Down 0.3 %

USPH stock opened at $88.49 on Friday. The company has a market cap of $1.34 billion, a price-to-earnings ratio of 94.14, a P/E/G ratio of 3.58 and a beta of 1.48. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63. The business has a 50 day moving average price of $92.67 and a two-hundred day moving average price of $88.94. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27.

U.S. Physical Therapy Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were paid a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.99%. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective on the stock. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their target price for the company from $100.00 to $115.00 in a research report on Monday, December 16th. Citizens Jmp raised U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JPMorgan Chase & Co. lifted their price objective on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Finally, Barrington Research restated an “outperform” rating and set a $108.00 target price on shares of U.S. Physical Therapy in a report on Thursday, November 21st. One investment analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, U.S. Physical Therapy has a consensus rating of “Buy” and a consensus target price of $114.00.

Insider Buying and Selling

In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the completion of the sale, the director now directly owns 16,726 shares of the company’s stock, valued at $1,554,681.70. This trade represents a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Nancy Ham sold 1,172 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the transaction, the director now owns 1,112 shares of the company’s stock, valued at $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,412 shares of company stock worth $706,605. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.